A Study to Assess the Pulmonary Safety of Staccato Alprazolam in Healthy Study Participants and in Study Participants With Mild Asthma

Summary

The purpose of the study is to assess the pulmonary safety of Staccato alprazolam in healthy study participants and in and study participants with mild asthma

Timeline

Start

2021-03-09

Primary completion

2021-11-22

Completion

2021-11-22

Publications

• Miller SD, LaForce CF, Barlow L, Watanabe S, King A, Burian M, Chanteux H. Pulmonary safety of Staccato alprazolam in healthy participants and participants with mild asthma: Phase 1, randomized, double-blind, placebo-controlled trial. Pulm Pharmacol Ther. 2026 Jun;93:102411. doi: 10.1016/j.pupt.2026.102411. Epub 2026 Feb 24.

Drugs

Indications